Table 1: Cases and parameters of COVID-19 and HIV co-infection, March 2020 to September 2020, UATH isolation centre Gwagwalada, Abuja, Nigeria, (n = 7).

Parameters	Cases
Parameters	Case 1	Case 2	Case 3	Case 4	Case 5	Case 6	Case 7
Age (years)	34	38	46	53	56	50	60
Gender	M	M	F	M	M	M	M
ART Regimen	Tenofovir Lamivudine Dolutegravir	Tenofovir Lamivudine Dolutegravir	Tenofovir Lamivudine Dolutegravir	Tenofovir Lamivudine Dolutegravir	Abacavir Lamivudine Lopinavir/ ritonavir	Tenofovir Lamivudine Atazanavir/ ritonavir	Tenofovir Lamivudine Dolutegravir
CD4 count(cells/ml)	580	450	600	320	330	650	420
Symptoms	fever	Loss of smell, poor appetite	Fever, headache	Fever, cough, breathlessness	Fever, vomiting, irrational behavior	Rhinorrhea	Fever, cough, breathlessness
Underlying comorbidity	None	None	Hypertension	Hypertension	Diabetes Chronic Kidney disease	None	Diabetes Hypertension
Temperature (°C)	35.5	36.6	36.8	36.5	38.2	36.6	36.7
Blood pressure (mmHg)	128/83	114/77	163/103	153/68	152/100	150/100	147/87
Pulse rate (beats/min)	82	76	123	112	102	76	84
Oxygen saturation in room air (%)	99	99	99	58	97	99	88
Chest X-ray	Normal	Normal	Normal	Ground-glass opacities	Cardiomegaly	Normal	Ground-glass opacities
Urea (Mmol/L)	3.3	2.9	4.6	5.1	49.4	3.0	4.0
Creatinine (Pmol/L)	72	80	62	90	1,391	76	65
White cell count ((cells per 10⁶/L)	5.0	4.2	6.7	8.9	5.3	6.6	9.4
Severity of disease	Mild	Mild	Mild	Severe	Severe	Mild	Severe
Length of hospital stay	15	10	8	8	17	13	13
Outcome	Cured	Cured	Cured	Cured	Cured	Cured	Cured